The increases were effective as of July 1 and in most cases were just over 9 per cent — well above the rate of inflation in the US, which is running at about 2 per cent.
President and Chief Executive Officer, Prime Therapeutics As president and CEO of Prime Therapeutics, Mostafa Kamal leads Prime and Magellan Rx as a unified pharmacy solutions enterprise alongside nearly 7,000 dedicated colleagues who are passionate about providing high-quality, affordable care
Pharmacy benefit companies actively promote the use of generics and biosimilars. Take a look at the data on drug utilization: 90 percent of prescriptions dispensed are generics or biosimilars. During last week’s hearing in the House Oversight Committee, Dr. Rena
PBMs: Committed to Helping Patients The Critical Path Forward: Rx Policies to Reduce Patient Costs, Improve Access For America’s pharmacy benefit managers, PBMs, our core mission is to increase access to affordable prescription drugs for all Americans. But more can
How PBMs are Helping Patients Access COVID-19 Vaccines
(Washington, D.C.) — As Congress begins to examine high prescription drug prices, the Pharmaceutical Care Management Association (PCMA) sent letters to several congressional committees highlighting the value pharmacy benefit managers (PBMs) provide to patients and payers as well as outlining
Johnny Garcia, PharmD Senior Director, Policy Johnny Garcia, PharmD is Senior Director, Policy for PCMA. He has more than two decades of pharmaceutical experience, having worked in many areas of the industry, including pharmacy retail, mail order pharmacy, specialty pharmacy,
Paying pharmacies more for dispensing medications will raise prescription drug costs without improving value.
Unlocking an Affordable Future Building Toward a More Accessible and Affordable Health Care Future As pharmacy benefit experts, our companies secure lower prescription drug costs, enable better health outcomes for patients, and offer employers and other health insurance plan sponsors
©2024 PCMA. All Rights Reserved.
